6Jeschke M G, Klein D, Hemdon D N. Insulin treatment improves the systemic inflammatory reaction to severe trauma [J]. Ann Surg, 2004,239(4) :553-560.
7Gandolfo S,Richiardi L,Carrozzo M,et al.Risk of oral squamous cell carcinoma in 402 patients with oral lichen planus:a follow-up study in an Italian population[J].Oral Oncol,2004,40(1):77-83.
5Farhi D, Dupin N. Pathophysiology, etiologic factors, and clinical management of oral lichen planus,part I:Facts and controversies [J]. Clin Dermatol, 2010,28( 1 ) : 100-108.
6Khan A, Farah C S, Savage N W, et al. Thl cytokines in oral lichen planus [J]. J Oral Pathol Med, 2003,32(2):77-83.
7Liu W, Dan H, Wang Z, et al. IFN-gamma and IL-4 in saliva of patients with oral lichen planus:A study in an ethnic Chinese population [ J ]. Inflammation, 2009,32 (3) : 176-181.
8lsmail S B, Kumar S K, Zain R B. Oral lichen planus and liehenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation [J]. A J Oral Sci, 2007,49(2): 89-106.
9Gotoh A, Hamada Y, Shiobara N, et al. Skew in T cell receptor usage with polyclonal expansion in lesions of oral lichen planus without hepatitis C virus infection [J]. Clin Exp Immunol, 2008,154 (2) : 192-201.
10Benucci M, Saviola G, Baiardi P, et al. Efficacy and safety of leflunomide or methotrexate plus subcutaneous turnout necrosis factor-alpha blocking agents in rheumatoid arthritis [J]. Int J Immunopathol Pharmacol, 2011 ; 24 ( 1 ) : 269-74.
